We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

138 hedge funds and large institutions have $430M invested in Voyager Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,285% more call options, than puts

Call options by funds: $830K | Put options by funds: $13K

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

18% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 40

5% more funds holding

Funds holding: 131 → 138 (+7)

0.17% more ownership

Funds ownership: 83.06% → 83.23% (+0.17%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

19% less capital invested

Capital invested by funds: $528M → $430M (-$98M)

Holders
138
Holders Change
+7
Holders Change %
+5.34%
% of All Funds
2.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
47
Reduced
40
Closed
18
Calls
$830K
Puts
$13K
Net Calls
+$817K
Net Calls Change
-$839K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$7.67M
2
Millennium Management
Millennium Management
New York
+$7.16M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$6.65M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.71M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$4.13M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$21.2M
2
BC
Boxer Capital
California
-$8.61M
3
Invesco
Invesco
Georgia
-$4.56M
4
ClearBridge Investments
ClearBridge Investments
New York
-$3.29M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
$89.2M – – –
BG
2
Bellevue Group
Switzerland
$37.7M -$5.81K -400 -0%
BlackRock
3
BlackRock
New York
$29.5M -$144K -9,910 -0.5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.2M +$4.71M +324,339 +18%
AC
5
Armistice Capital
New York
$22.7M +$7.67M +528,000 +48%
State Street
6
State Street
Massachusetts
$18.5M -$1.24M -85,139 -6%
Renaissance Technologies
7
Renaissance Technologies
New York
$17.4M +$2.51M +172,600 +16%
CC
8
Casdin Capital
New York
$15.3M -$480K -33,000 -3%
Federated Hermes
9
Federated Hermes
Pennsylvania
$14.3M +$4.13M +284,022 +38%
ClearBridge Investments
10
ClearBridge Investments
New York
$13.7M -$3.29M -226,628 -18%
FCMI
11
Foresite Capital Management IV
California
$11.6M – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$7.78M +$6.65M +457,473 +457%
Citadel Advisors
13
Citadel Advisors
Florida
$6.95M +$1.46M +100,161 +25%
Millennium Management
14
Millennium Management
New York
$6.87M +$7.16M +492,663 New
Wellington Management Group
15
Wellington Management Group
Massachusetts
$6.68M – – –
Goldman Sachs
16
Goldman Sachs
New York
$5.83M +$96K +6,602 +2%
N
17
Nuveen
North Carolina
$5.79M -$1.56M -107,086 -21%
Wells Fargo
18
Wells Fargo
California
$5.42M +$424K +29,178 +8%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$5.35M +$46.9K +3,227 +0.8%
Northern Trust
20
Northern Trust
Illinois
$4.68M -$2.83K -195 -0.1%
EAM
21
Erste Asset Management
Austria
$4.33M +$218K +15,000 +5%
UBS AM
22
UBS AM
Illinois
$4.1M -$275K -18,945 -6%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$3.21M -$2.38M -163,400 -42%
JP Morgan Chase
24
JP Morgan Chase
New York
$3.19M +$430K +29,569 +15%
Charles Schwab
25
Charles Schwab
California
$2.85M +$77K +5,299 +3%
1
2 3 4 5

VYGR Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2019, worth a combined $430M — down 19% from $528M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new VYGR positions and 18 closed out — a net gain of 8 holders — while 47 added to existing stakes and 40 trimmed.

The largest buyer was Armistice Capital, adding an estimated $7.67M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $21.2M sold.

  • 138 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2019, up from 131 in Q3 2019.
  • Funds reported $430M of Voyager Therapeutics stock for Q4 2019, down 19% quarter-over-quarter.
  • 26 funds opened new Voyager Therapeutics positions in Q4 2019 and 18 closed out, a net change of +8 holders.
  • The largest Voyager Therapeutics buyer in Q4 2019 was Armistice Capital, an estimated $7.67M added.
  • The largest Voyager Therapeutics seller in Q4 2019 was PFM Health Sciences, an estimated $21.2M sold.

Based on aggregated 13F filings for Q4 2019.